![]() |
![]() |
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| High-volume production, low profit margin | Low-volume production, high profit margin | ||
| Medical and surgical products, e.g., bandages and syringes | Diagnostic products, e.g., testing products, in vitro, imaging | High-tech, high-value products, e.g., implantable devices such as pacemakers | Capital equipment, e.g., x-ray or MRI machines |
It's also important to understand the developmental and approval phases that medical device companies must follow to comply with FDA regulations. The graphic below gives you the gist of it, and you can find explanations of each phase by clicking on the topics in the original graphic on the Medical Device Consultants site.
![]()
![]()
![]()
![]()
![]()

Source:
Medical Device Consultants, Inc. (MDCI). Copyright 2003 MDCI.
Used by permission.
Industry forecast
According to industry analysts Frost & Sullivan, "The U.S. market for medical devices exceeds $55 billion and continues to grow, thanks to an aging population and technological advances that help improve health and lengthen lifespans." Forrester Research, one of their competitors, agrees, saying in a preview for a forthcoming report, "Medical device firms will thrive on patients' avoidance of nursing homes and hospitals and payers' desire to minimize costly in-patient care. But," they caution, "acceptance, compliance and reimbursement hurdles prevent medical device companies and pharma from capitalizing on these opportunities."
Even some of those roadblocks aren't quite the deterrents they were a year ago, though, says Kirk Walden, Director of Venture Capital Research for PricewaterhouseCoopers (PWC). "The FDA has been increasingly cooperative in getting new drugs approved. Reimbursement is getting enough discussion that, if it continues along this path, a lot of things will qualify for reimbursement with less hassle, and that will stimulate the market."
Just as important for those of us in Silicon Valley, Walden says: "Nationally, biotech will typically get more funding, but that may not be the case in Silicon Valley. Silicon Valley accounts for 40% of all software investments in the US last year, but 29% of all investments for medical devices. Medical devices and biotech are historically solid VC investing categories. Taken together, they're becoming more dominant nationwide. Silicon Valley is ground zero for venture capital. It is going to have the dominant share of any industry, because all the VCs are there."
Walden's firm, PricewaterhouseCoopers, co-issues the quarterly MoneyTree VC funding analysis. There's an interactive version on their site, which you can customize by region, industry and so on. Their 2002 results show that Silicon Valley is home to the most medical device manufacturers, with New England (mainly the Boston area) and San Diego as the next-closest hubs of activity:
|
MoneyTree™ Survey* |
|
| Amount Invested |
2002 |
| AK/HI/PR |
$2,900,000 |
| Colorado |
67,130,000 |
| DC/Metroplex |
123,130,000 |
| LA/Orange County |
57,640,200 |
| Midwest |
132,139,200 |
| New England |
530,515,100 |
| North Central |
41,216,100 |
| Northwest |
61,660,200 |
| NY Metro |
185,751,400 |
| Other
|
|
| Philadelphia Metro |
167,767,100 |
| Sacramento/N.Cal |
|
| San Diego |
422,050,900 |
| Silicon Valley |
715,258,200 |
| South Central |
|
| Southeast |
214,591,300 |
| Southwest |
13,829,900 |
| Texas |
47,690,000 |
| Upstate NY |
15,000,000 |
| Grand Total |
$2,798,269,600 |
| Number of Deals |
2002 |
| AK/HI/PR |
1 |
| Colorado |
5 |
| DC/Metroplex |
18 |
| LA/Orange County |
8 |
| Midwest |
38 |
| New England |
40 |
| North Central |
6 |
| Northwest |
11 |
| NY Metro |
16 |
| Other
|
|
| Philadelphia Metro |
20 |
| Sacramento/N.Cal |
|
| San Diego |
30 |
| Silicon Valley |
58 |
| South Central |
|
| Southeast |
22 |
| Southwest |
6 |
| Texas |
8 |
| Upstate NY |
1 |
| Grand Total |
288 |
Source:
PricewaterhouseCoopers/Thomson
Venture Economics/National Venture Capital Association MoneyTree
Survey, Biotechnology Venture Capital Investments by Region, 1998-2002.
Copyright © 2003, all rights reserved. Used by permission.
Even within
healthcare technologies, Frost & Sullivan's 2002 report (see Resources)
says, "the lines between traditional healthcare technologies are
blurring as combination products are launched for the diagnosis and treatment
of many different conditions. Image-guided surgery uses medical imaging
technologies such as CT and MRI in conjunction with specialized surgical
instrumentation. Drug-coated stents combine a medical device with a pharmaceutical
formulation. As our analyst says, 'Combination products are expected
to drive future market growth and be the key to bringing in revolutionary
therapies.'"
Career crossover paths
Medical devices also have something in common with hardware and software. As a February 20, 2003 article in the Silicon Valley/San Jose Business Journal said, "Medical devices require the expertise of engineers to build equipment that can be small enough to operate in the human body and perform its function. Software engineers are involved in the design and development of chips that can be used to operate medical devices." Many, however, are biomedical engineers with narrowly defined subspecialties. If you're willing to go back to school for a master's or PhD, that's the direction to explore. You'll find links to academic programs and much more to help you get oriented on the Biomedical Engineering Network's site.
The FDA mandates documentation (more often called “labeling” in the device field, usually overseen by each company's Regulatory and Compliance department), so they need tech writers and editors, too. To control sales costs, device manufacturers are experimenting with online ordering and auctions of both new and used equipment, so that means they also need e-commerce and supply chain experts. And of course, there are opportunities for people with experience in all phases of manufacturing, HR and marketing.
How and where to look for jobs
In the introduction to their February 26, 2003 report on the U.S. Medical Devices Market Outlook, Frost & Sullivan's analysts say, "In this highly competitive industry, increased spending on R&D is a sign of a company's sustained commitment to achieving long-term success." So watch the quarterly MoneyTree VC funding report in the San Jose Mercury News for R&D funding for device companies.
Sometimes, initial phases of research are conducted by contract research organizations (CROs), which put together special teams to do the work commissioned by the device companies. That's sometimes an easier way to break in than working directly for the companies.
To learn
more, monitor industry news, join one or two of the leading trade associations
(many have lower rates for restricted access first-year membership), attend
professional association meetings and conferences, read the trade magazines
in the field (including the ads and bylines). You'll find links to good
places to start your research in the Resources
section that follows.
Note: I wrote the first version of this article for a Silcon Valley, San Francisco Bay area audience, so some of the info below is slanted in that direction. Judith
Helpful Web sites
Medical device companies
Industry associations
Key government sites
Home *
Recent Articles by Topic
* Tips
and Recommendations *
info@polishedprose.com
* 831.336.4232
(Pacific time, USA)
Copyright
© 2003, Judith Broadhurst. All rights reserved.
All trademarks and service marks protected through Registering
a Trademark.